immunoact: Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACT
Laurus Labs on Wednesday invested additional Rs 80 crore within the Immunoadoptive Cell Remedy Personal Ltd (lmmunoACT), that is creating ...
Laurus Labs on Wednesday invested additional Rs 80 crore within the Immunoadoptive Cell Remedy Personal Ltd (lmmunoACT), that is creating ...
Copyright © 2022 Asia Today.